Changes in IGFs in cardiac tissue following myocardial infarction

Citation
Kg. Matthews et al., Changes in IGFs in cardiac tissue following myocardial infarction, J ENDOCR, 163(3), 1999, pp. 433-445
Citations number
43
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF ENDOCRINOLOGY
ISSN journal
00220795 → ACNP
Volume
163
Issue
3
Year of publication
1999
Pages
433 - 445
Database
ISI
SICI code
0022-0795(199912)163:3<433:CIIICT>2.0.ZU;2-G
Abstract
We have studied changes in the IGF axis in an ovine model of myocardial inf arction (MI), in order to determine the relationship between time-based cha nges in post-infarct myocardium and IGF levels. IGF localization was studie d by immunocytochemistry, production by in situ hybridization, and specific binding by radioligand studies. In surviving tissue, IGF-I peptide localized to cardiomyocytes, with strong est immunostaining at 1 and 2 days post-infarct in the immediate border are a adjoining the infarct, where IGF-I mRNA also increased, reaching a maximu m at 2 days. Binding of radiolabelled IGF-I in surviving tissue was initial ly lower than that seen in cardiomyocytes in control myocardium, subsequent ly increasing to become significantly greater by 6 days post-infarct. In necrotic tissue, IGF-I peptide was still detectable in cardiomyocytes at 0.5 days post-infarct, but had cleared From this area by 1 day, becoming d etectable again at 6 days post-infarct in macrophages and fibroblasts infil trating the repair zone. IGF-I mRNA was not detected in necrotic tissue unt il 6 days, when probe hybridized to macrophages and fibroblasts. Within the necrotic zone, high levels of radiolabelled IGF-I binding to a combination of receptors and binding proteins were observed in cardiomyocytes in islan ds of viable tissue located close to the border. Weak immunostaining for IGF-II was observed in cardiomyocytes of the surviv ing tissue. IGF-II mRNA was not detected in either surviving or necrotic ar eas. Binding of radiolabelled IGF-II was predominantly to macrophages in bo th surviving and infarct areas, although as with IGF-I, high levels of bind ing of radiolabelled IGF-II to a combination of receptors and binding prote ins were observed in islands of viable tissue close to the border within th e necrotic area. We conclude that, following MI, surviving cardiomyocytes at the infarct bor der show marked changes in IGF-I localization, production, and specific bin ding, indicating that the IGF axis is directly involved in post-infarct eve nts, possibly in the maintenance of cardiac function by the induction of hy pertrophy and in cell survival by decreasing apoptotic cell death, which ha s been demonstrated in other cell types.